CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling

Authors:

Abstract
No abstract available
Funding Information
  • EMBO
  • Medical Research Council (U105192732)
  • Lundbeck Foundation
  • European Research Council (309756)
  • Deutsche Krebshilfe (111738)
  • Lister Institute of Preventive Medicine
  • Deutsche Forschungsgemeinschaft (FOR2036)
  • Else Kröner-Fresenius-Stiftung (2014_A185)
  • Wellcome Trust (102894/Z/13/Z)
  • Ludwig Institute for Cancer Research